Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26FE6H7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,092
Award facts
- Contract value 100% obligated
- $7,091.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with a ceiling value of $7,091.96. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 7, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military and federal healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania and serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company has demonstrated substantial capability in fulfilling federal medical supply requirements through its extensive portfolio of competitive contract awards with the DLA, covering diabetes medications, specialty pharmaceuticals, and other therapeutic products. This specific delivery order for Zepbound, a diabetes treatment medication, reflects the company's ongoing role in supplying essential pharmaceutical products to support Department of Defense and other federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26FE6H7?
SPE2DR26FE6H7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26FE6H7 worth?
The government has obligated $7,092 on SPE2DR26FE6H7.
Is contract SPE2DR26FE6H7 an order under another contract?
Yes. SPE2DR26FE6H7 is a delivery order under SPE2DR25D2005, an indefinite delivery contract.
Was contract SPE2DR26FE6H7 competed?
The extent of competition for SPE2DR26FE6H7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award